2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Management of Resistant Hypertension

L Lauder, F Mahfoud, M Böhm - Annual Review of Medicine, 2024 - annualreviews.org
Resistant hypertension (RH) is a severe form of hypertension associated with increased
cardiovascular risk. Although true RH affects less than 10% of the patients receiving …

Randomized trials of renal denervation for uncontrolled hypertension: an updated meta‐analysis

SH Mufarrih, NQ Qureshi, MS Khan… - Journal of the …, 2024 - ahajournals.org
Background Despite optimal medical therapy, a significant proportion of patients' blood
pressure remains uncontrolled. Catheter‐based renal denervation (RDN) has been …

[PDF][PDF] 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

M Brunström, M Burnier… - Journal of …, 2023 - docred-strapi-cms-prod.s3.sa-east-1 …
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Safety and efficacy of renal denervation in patients taking antihypertensive medications

DE Kandzari, RR Townsend, K Kario, F Mahfoud… - Journal of the American …, 2023 - jacc.org
Background Renal denervation (RDN) reduces blood pressure (BP) in patients with
uncontrolled hypertension in the absence of antihypertensive medications. Objectives This …

Patient-level pooled analysis of endovascular ultrasound renal denervation or a sham procedure 6 months after medication escalation: the RADIANCE clinical trial …

M Azizi, ASP Sharp, NDL Fisher, MA Weber, MD Lobo… - Circulation, 2024 - Am Heart Assoc
BACKGROUND: The randomized, sham-controlled RADIANCE-HTN (A Study of the Recor
Medical Paradise System in Clinical Hypertension) SOLO, RADIANCE-HTN TRIO, and …

The Current State and Future of Renal Denervation: A Review

AS Maini, M Maini, T Addo, V Koshti, T Koshy… - Trends in …, 2024 - Elsevier
Renal denervation as an option for difficult to treat hypertension has been a concept for
several decades, with recent US FDA approval of new, minimally invasive devices …

Real-world experience with ultrasound renal denervation utilizing home blood pressure monitoring: the Global Paradise System registry study design

F Mahfoud, M Azizi, J Daemen, ASP Sharp… - Clinical Research in …, 2023 - Springer
Background Hypertension is a major public health issue due to its association with
cardiovascular disease risk. Despite the availability of effective antihypertensive drugs, rates …

Renal denervation: recent developments in clinical and preclinical research

P Drawz, D Baumann, A Dayton - Current opinion in nephrology …, 2023 - journals.lww.com
Studies of renal denervation continue to find a robust antihypertensive effect, especially in
studies wherein medications are withdrawn. Further investigation into mechanisms and …

Taming resistant hypertension: The promise of novel pharmacologic approaches and renal denervation

O Azzam, SH Nejad, R Carnagarin… - British Journal of …, 2024 - Wiley Online Library
Resistant hypertension is associated with an exceedingly high cardiovascular risk and there
remains an unmet therapeutic need driven by pathophysiologic pathways unaddressed by …